Arul M Chinnaiyan
S P Hicks Endowed Professor of Pathology
Section Head
Michigan Center for Translational Pathology
Professor of Pathology
Professor of Urology
[email protected]

Available to mentor

Arul M Chinnaiyan
Professor
  • Center Memberships
  • Recent Publications
  • Center Memberships
    • Center Member
      MM-PKUHSC Joint Institute
    • Center Member
      Taubman Institute
    • Center Member
      Precision Health Initiative
    • Center Member
      Global REACH
    • Center Member
      Rogel Cancer Center
    • Center Member
      Center for Computational Medicine and Bioinformatics
    Recent Publications See All Publications
    • Journal Article
      CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue.
      van Riet J, Saha C, Strepis N, Brouwer RWW, Martens-Uzunova ES, van de Geer WS, Swagemakers SMA, Stubbs A, Halimi Y, Voogd S, Tanmoy AM, Komor MA, Hoogstrate Y, Janssen B, Fijneman RJA, Niknafs YS, Chinnaiyan AM, van IJcken WFJ, van der Spek PJ, Jenster G, Louwen R. Commun Biol, 2022 Apr 8; 5 (1): 338 DOI:10.1038/s42003-022-03249-4
      PMID: 35396392
    • Journal Article
      CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue.
      van Riet J, Saha C, Strepis N, Brouwer RWW, Martens-Uzunova ES, van de Geer WS, Swagemakers SMA, Stubbs A, Halimi Y, Voogd S, Tanmoy AM, Komor MA, Hoogstrate Y, Janssen B, Fijneman RJA, Niknafs YS, Chinnaiyan AM, van IJcken WFJ, van der Spek PJ, Jenster G, Louwen R. Commun Biol, 2022 Apr 8; 5 (1): 338 DOI:10.1038/s42003-022-03249-4
      PMID: 35396392
    • Journal Article
      Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer.
      Dadhania V, Gonzalez D, Yousif M, Cheng J, Morgan TM, Spratt DE, Reichert ZR, Mannan R, Wang X, Chinnaiyan A, Cao X, Dhanasekaran SM, Chinnaiyan AM, Pantanowitz L, Mehra R. BMC Cancer, 2022 May 5; 22 (1): 494 DOI:10.1186/s12885-022-09559-4
      PMID: 35513774
    • Journal Article
      Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer.
      Dadhania V, Gonzalez D, Yousif M, Cheng J, Morgan TM, Spratt DE, Reichert ZR, Mannan R, Wang X, Chinnaiyan A, Cao X, Dhanasekaran SM, Chinnaiyan AM, Pantanowitz L, Mehra R. BMC Cancer, 2022 May 5; 22 (1): 494 DOI:10.1186/s12885-022-09559-4
      PMID: 35513774
    • Journal Article
      PD40-07 CLINICAL DECISION ALGORITHM USING RESTRICTION SPECTRUM IMAGING AND BIOMARKERS TO PREDICT UPGRADING IN ACTIVE SURVEILLANCE
      Eng S, Basasie B, Lam A, Semmes J, Troyer D, Clarke G, Sunnapwar A, Leach R, Johnson-Pais T, Sokoll L, Chan D, Tosoian J, Siddiqui J, Chinnaiyan A, Boutros P, Liss M. Journal of Urology, 2022 May; 207 (Supplement 5): e686 DOI:10.1097/ju.0000000000002601.07
    • Journal Article
      PD40-07 CLINICAL DECISION ALGORITHM USING RESTRICTION SPECTRUM IMAGING AND BIOMARKERS TO PREDICT UPGRADING IN ACTIVE SURVEILLANCE
      Eng S, Basasie B, Lam A, Semmes J, Troyer D, Clarke G, Sunnapwar A, Leach R, Johnson-Pais T, Sokoll L, Chan D, Tosoian J, Siddiqui J, Chinnaiyan A, Boutros P, Liss M. Journal of Urology, 2022 May; 207 (Supplement 5): e686 DOI:10.1097/ju.0000000000002601.07
    • Journal Article
      A transcriptomic model for homologous recombination deficiency in prostate cancer.
      Weiner AB, Liu Y, McFarlane M, Bawa PS, Li EV, Zhao X, Li Z, Hammoud T, Hazime M, Karnes RJ, Davicioni E, Reichert ZR, Chinnaiyan AM, Lotan TL, Spratt DE, Schaeffer EM. Prostate Cancer Prostatic Dis, 2022 Apr; 25 (4): 659 - 665. DOI:10.1038/s41391-021-00416-2
      PMID: 34226663
    • Journal Article
      Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer.
      Labanca E, Yang J, Shepherd PDA, Wan X, Starbuck MW, Guerra LD, Anselmino N, Bizzotto JA, Dong J, Chinnaiyan AM, Ravoori MK, Kundra V, Broom BM, Corn PG, Troncoso P, Gueron G, Logothethis CJ, Navone NM. Eur Urol Oncol, 2022 Apr; 5 (2): 164 - 175. DOI:10.1016/j.euo.2021.10.001
      PMID: 34774481
    Featured News & Stories Sewing Machine Cell Fabric Tangled
    Health Lab
    Research points to potential new treatment for aggressive prostate cancer subtype
    In two separate papers, U-M researchers describe how a gene alteration drives prostate cancer and a potential degrader that stops it
    blue cells close up with orangey see through circle going in and an explosion of bright yellow orange to the far left in that circle with purple circles floating in background
    Health Lab
    Researchers identify factor that drives prostate cancer-causing genes
    Researchers have uncovered a key reason why a typically normal protein goes awry and fuels cancer. They found the protein NSD2 alters the function of the androgen receptor, an important regulator of normal prostate development.
    blue purple cell dots on white background all over in different patterns
    Health Lab
    Research finds possible therapies to target oncogenic transcription factors in multiple cancer types
    A study from the University of Michigan Health Rogel Cancer Center furthers research that suggests the potential of developing new cancer treatments to target oncogenic transcription factors by indirectly affecting their ability to access enhancer DNA in chromatin.